 |
|
Pertussis—United States, 1997-2000
JAMA. 2002;287:977-979.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
MMWR. 2002;51:73-76
1 table omitted
Pertussis was a major cause of morbidity and mortality among infants and children in the United States during the prevaccine era (i.e., before the mid-1940s). Following the introduction and widespread use of whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids (DTP) among infants and children in the late 1940s, the incidence of reported pertussis declined to a historic low of 1,010 cases in 1976 (Figure 1). However, since the early 1980s, reported pertussis incidence has increased cyclically with peaks occurring every 3-4 years.1 In 1996, less reactogenic acellular pertussis vaccines (DTaP) were licensed and recommended for routine use among infants.2 This report summarizes national surveillance data for pertussis during 1997-2000 and assesses the effectiveness of pertussis vaccination in the United States during this period. The findings indicate that pertussis incidence continues to increase in infants too young to receive 3 doses of . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
O Antigen Protects Bordetella parapertussis from Complement
Goebel et al.
Infect. Immun. 2008;76:1774-1780.
ABSTRACT
| FULL TEXT
The O Antigen Enables Bordetella parapertussis To Avoid Bordetella pertussis-Induced Immunity
Wolfe et al.
Infect. Immun. 2007;75:4972-4979.
ABSTRACT
| FULL TEXT
Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence.
Omer et al.
JAMA 2006;296:1757-1763.
ABSTRACT
| FULL TEXT
On-Time Immunization Rates Among Children Who Enter Chicago Public Schools
Dominguez et al.
Pediatrics 2004;114:e741-e747.
ABSTRACT
| FULL TEXT
|
